Autolus Therapeutics

Tomorrow, September 20, 2025, marks the third annual World ALL Day. This year’s campaign aims to improve understanding of acute lymphoblastic leukemia, provide support to patients and caregivers through the stages of the patient journey, and to unite the community. To learn more about WORLD ALL Day and KNOWALL visit: https://lnkd.in/gBUVsq9A

Same mission, new name! Congratulations to The Leukemia & Lymphoma Society - now Blood Cancer United. Thank you for everything you do in support of people with blood cancer. https://lnkd.in/e-SrhKbk

For investors and analysts: Today we reported Q2 2025 financial results. To view the press release please visit: https://lnkd.in/dxeurHF6

We are proud to join The Leukemia & Lymphoma Society honoring survivors and recognizing National Cancer Survivors Month. Our work is motivated by you.

For investors and analysts We are looking forward to seeing many of you at upcoming investor conferences, including William Blair Growth Stock Conference, Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference. https://lnkd.in/ewMZeM8P

For investors and analysts As we approach World Lupus Day on May 10, we take this opportunity to highlight the importance of raising awareness about this complex autoimmune condition that affects millions worldwide. Autolus is proud to support organisations dedicated to finding solutions and improving the quality of life for lupus patients globally. Discover how you can make a difference by visiting https://worldlupusday.org/. #MakeLupusVisible #Awareness #Autolus

For investors and analysts Today at 8:30am ET / 13:30pm BST we look forward to presenting an update on our clinical pipeline, including plans to expand the obe-cel opportunity in autoimmune diseases. To view the webcast, please visit the Events section of our Investor Relations website: https://lnkd.in/eYcZv3Yn

For investors and analysts We are looking forward to presenting an update on our clinical pipeline programs in our upcoming R&D investor event on April 23rd. https://lnkd.in/ePTFFPqK

For investors and analysts Today we announced operational and financial results for year-end 2024. It was a year of strong execution leading to significant achievements for Autolus, including our strategic deal with BioNTech and corresponding financing to bolster our balance sheet, commencing GMP operations at our in-house CAR T manufacturing facility, and finishing the year with our first FDA approval and commercial launch. To access a live webcast of our earnings conference call at 8:30am ET / 12:30pm GMT, please visit: https://lnkd.in/eYcZv3Yn

For Investors and Analysts Today we announced a business update and an overview of our 2025 anticipated milestones. We are looking forward to a busy and productive J.P. Morgan Healthcare Conference! https://lnkd.in/eisVFNzk